메뉴 건너뛰기




Volumn 4, Issue 12, 2012, Pages

Oncogenes in cell survival and cell death

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GROWTH FACTOR RECEPTOR;

EID: 84870747810     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a009829     Document Type: Article
Times cited : (104)

References (70)
  • 1
    • 23144464363 scopus 로고    scopus 로고
    • Transcriptional regulation and transformation byMyc proteins
    • Adhikary S, Eilers M. 2005. Transcriptional regulation and transformation byMyc proteins. Nat Rev Mol Cell Biol 6: 635-645.
    • (2005) Nat Rev Mol Cell Biol , vol.6 , pp. 635-645
    • Adhikary, S.1    Eilers, M.2
  • 2
    • 27844562649 scopus 로고    scopus 로고
    • Tuberous sclerosis complex: Linking growth and energy signaling pathways with human disease
    • Astrinidis A, Henske EP. 2005. Tuberous sclerosis complex: Linking growth and energy signaling pathways with human disease. Oncogene 24: 7475-7481.
    • (2005) Oncogene , vol.24 , pp. 7475-7481
    • Astrinidis, A.1    Henske, E.P.2
  • 5
    • 62049084053 scopus 로고    scopus 로고
    • MYC-inducedmyeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
    • Beverly LJ, Varmus HE. 2009. MYC-inducedmyeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family. Oncogene 28: 1274-1279.
    • (2009) Oncogene , vol.28 , pp. 1274-1279
    • Beverly, L.J.1    Varmus, H.E.2
  • 6
    • 0035881691 scopus 로고    scopus 로고
    • Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter
    • Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, Eilers M, Luscher B. 2001. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15: 2042-2047.
    • (2001) Genes Dev , vol.15 , pp. 2042-2047
    • Bouchard, C.1    Dittrich, O.2    Kiermaier, A.3    Dohmann, K.4    Menkel, A.5    Eilers, M.6    Luscher, B.7
  • 7
    • 78049371811 scopus 로고    scopus 로고
    • Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
    • Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S. 2010. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. Blood 116: 3197-3207.
    • (2010) Blood , vol.116 , pp. 3197-3207
    • Campbell, K.J.1    Bath, M.L.2    Turner, M.L.3    Vandenberg, C.J.4    Bouillet, P.5    Metcalf, D.6    Scott, C.L.7    Cory, S.8
  • 9
    • 79960055459 scopus 로고    scopus 로고
    • RAS interactionwith PI3K: More than just another effector pathway
    • Castellano E, Downward J. 2010. RAS interactionwith PI3K: More than just another effector pathway. Genes Cancer 2: 261-274.
    • (2010) Genes Cancer , vol.2 , pp. 261-274
    • Castellano, E.1    Downward, J.2
  • 11
    • 1642553461 scopus 로고    scopus 로고
    • The dark side of Ras: Regulation of apoptosis
    • Cox AD, Der CJ. 2003. The dark side of Ras: Regulation of apoptosis. Oncogene 22: 8999-9006.
    • (2003) Oncogene , vol.22 , pp. 8999-9006
    • Cox, A.D.1    Der, C.J.2
  • 13
    • 0033635235 scopus 로고    scopus 로고
    • 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation
    • Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME. 2000. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41-51.
    • (2000) Mol Cell , vol.6 , pp. 41-51
    • Datta, S.R.1    Katsov, A.2    Hu, L.3    Petros, A.4    Fesik, S.W.5    Yaffe, M.B.6    Greenberg, M.E.7
  • 15
    • 58149398623 scopus 로고    scopus 로고
    • Translation of the Philadelphia chromosome into therapy for CML
    • Druker BJ. 2008. Translation of the Philadelphia chromosome into therapy for CML. Blood 112: 4808-4817.
    • (2008) Blood , vol.112 , pp. 4808-4817
    • Druker, B.J.1
  • 16
    • 1942437456 scopus 로고    scopus 로고
    • Bim is a suppressor ofMyc-induced mouse B cell leukemia
    • Egle A, Harris AW, Bouillet P, Cory S. 2004. Bim is a suppressor ofMyc-induced mouse B cell leukemia. Proc Natl Acad Sci 101: 6164-6169.
    • (2004) Proc Natl Acad Sci , vol.101 , pp. 6164-6169
    • Egle, A.1    Harris, A.W.2    Bouillet, P.3    Cory, S.4
  • 17
    • 0033569422 scopus 로고    scopus 로고
    • Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
    • Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13: 2658-2669.
    • (1999) Genes Dev , vol.13 , pp. 2658-2669
    • Eischen, C.M.1    Weber, J.D.2    Roussel, M.F.3    Sherr, C.J.4    Cleveland, J.L.5
  • 18
    • 67749122122 scopus 로고    scopus 로고
    • Targeting PI3K signalling in cancer: Opportunities, challenges and limitations
    • Engelman JA. 2009. Targeting PI3K signalling in cancer: Opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562.
    • (2009) Nat Rev Cancer , vol.9 , pp. 550-562
    • Engelman, J.A.1
  • 19
    • 33746257209 scopus 로고    scopus 로고
    • The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
    • Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619.
    • (2006) Nat Rev Genet , vol.7 , pp. 606-619
    • Engelman, J.A.1    Luo, J.2    Cantley, L.C.3
  • 22
    • 0033180211 scopus 로고    scopus 로고
    • Reversible tumorigenesis by MYC in hematopoietic lineages
    • Felsher DW, Bishop JM. 1999. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4 199-207.
    • (1999) Mol Cell , vol.4 , pp. 199-207
    • Felsher, D.W.1    Bishop, J.M.2
  • 23
    • 79960052850 scopus 로고    scopus 로고
    • Ras in cancer and developmental diseases
    • Fernandez-Medarde A, Santos E. 2011. Ras in cancer and developmental diseases. Genes Cancer 2: 344-358.
    • (2011) Genes Cancer , vol.2 , pp. 344-358
    • Fernandez-Medarde, A.1    Santos, E.2
  • 25
    • 77749279644 scopus 로고    scopus 로고
    • Myc proteins as therapeutic targets
    • GustafsonWC,WeissWA
    • GustafsonWC,WeissWA. 2010.Myc proteins as therapeutic targets. Oncogene 29: 1249-1259.
    • (2010) Oncogene , vol.29 , pp. 1249-1259
  • 26
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
    • (2000) Cell , vol.100 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 27
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 30
    • 44949215822 scopus 로고    scopus 로고
    • The TSC1-TSC2 complex is required for proper activation of mTOR complex 2
    • Huang J, Dibble CC, Matsuzaki M, Manning BD. 2008. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 28: 4104-4115.
    • (2008) Mol Cell Biol , vol.28 , pp. 4104-4115
    • Huang, J.1    Dibble, C.C.2    Matsuzaki, M.3    Manning, B.D.4
  • 32
    • 51349108718 scopus 로고    scopus 로고
    • Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/ mTOR inhibitor prevents expansion of human BCRABL {thorn} leukemia cells
    • Kharas MG, Janes MR, Scarfone VM, Lilly MB, Knight ZA, Shokat KM, Fruman DA. 2008. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/ mTOR inhibitor prevents expansion of human BCRABL {thorn} leukemia cells. J Clin Invest 118: 3038-3050.
    • (2008) J Clin Invest , vol.118 , pp. 3038-3050
    • Kharas, M.G.1    Janes, M.R.2    Scarfone, V.M.3    Lilly, M.B.4    Knight, Z.A.5    Shokat, K.M.6    Fruman, D.A.7
  • 33
    • 0030592517 scopus 로고    scopus 로고
    • Lessons from hereditary colorectal cancer
    • Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87: 159-170.
    • (1996) Cell , vol.87 , pp. 159-170
    • Kinzler, K.W.1    Vogelstein, B.2
  • 34
    • 0032524104 scopus 로고    scopus 로고
    • Landscaping the cancer terrain
    • Kinzler KW, Vogelstein B. 1998. Landscaping the cancer terrain. Science 280: 1036-1037.
    • (1998) Science , vol.280 , pp. 1036-1037
    • Kinzler, K.W.1    Vogelstein, B.2
  • 35
    • 54049088959 scopus 로고    scopus 로고
    • BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress
    • Koptyra M, Cramer K, Slupianek A, Richardson C, Skorski T. 2008. BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 22: 1969-1972.
    • (2008) Leukemia , vol.22 , pp. 1969-1972
    • Koptyra, M.1    Cramer, K.2    Slupianek, A.3    Richardson, C.4    Skorski, T.5
  • 36
    • 0035839959 scopus 로고    scopus 로고
    • Mechanisms of chromosomal translocations in B cell lymphomas
    • Kuppers R, Dalla-Favera R. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20: 5580-5594.
    • (2001) Oncogene , vol.20 , pp. 5580-5594
    • Kuppers, R.1    Dalla-Favera, R.2
  • 38
    • 70350241382 scopus 로고    scopus 로고
    • C-Myc and eIF4F constitute a feedforward loop that regulates cell growth: Implications for anticancer therapy
    • Lin CJ, Malina A, Pelletier J. 2009. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: Implications for anticancer therapy. Cancer Res 69: 7491-7494.
    • (2009) Cancer Res , vol.69 , pp. 7491-7494
    • Lin, C.J.1    Malina, A.2    Pelletier, J.3
  • 39
    • 68249093818 scopus 로고    scopus 로고
    • Targeting the phosphoinositide 3-kinase pathway in cancer
    • Liu P, Cheng H, Roberts TM, Zhao JJ. 2009. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 627-644
    • Liu, P.1    Cheng, H.2    Roberts, T.M.3    Zhao, J.J.4
  • 40
    • 9244224723 scopus 로고    scopus 로고
    • Intrinsic tumour suppression
    • Lowe SW, Cepero E, Evan G. 2004. Intrinsic tumour suppression. Nature 432: 307-315.
    • (2004) Nature , vol.432 , pp. 307-315
    • Lowe, S.W.1    Cepero, E.2    Evan, G.3
  • 44
    • 56749184298 scopus 로고    scopus 로고
    • Reflecting on 25 years with MYC
    • Meyer N, Penn LZ. 2008. Reflecting on 25 years with MYC. Nat Rev Cancer 8: 976-990.
    • (2008) Nat Rev Cancer , vol.8 , pp. 976-990
    • Meyer, N.1    Penn, L.Z.2
  • 48
    • 0034584880 scopus 로고    scopus 로고
    • STI571: An inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia
    • O'Dwyer ME, Druker BJ. 2000. STI571: An inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia. Lancet Oncol 1: 207-211.
    • (2000) Lancet Oncol , vol.1 , pp. 207-211
    • O'Dwyer, M.E.1    Druker, B.J.2
  • 49
    • 0028356521 scopus 로고
    • E2F-dependent regulation of human MYC: Trans-activation by cyclins D1 and A overrides tumour suppressor protein functions
    • Oswald F, Lovec H, Moroy T, Lipp M. 1994. E2F-dependent regulation of human MYC: Trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oncogene 9: 2029-2036.
    • (1994) Oncogene , vol.9 , pp. 2029-2036
    • Oswald, F.1    Lovec, H.2    Moroy, T.3    Lipp, M.4
  • 50
    • 77954977940 scopus 로고    scopus 로고
    • Chronic myeloid leukemia: Mechanisms of blastic transformation
    • Perrotti D, Jamieson C, Goldman J, Skorski T. 2010. Chronic myeloid leukemia: Mechanisms of blastic transformation. J Clin Invest 120: 2254-2264.
    • (2010) J Clin Invest , vol.120 , pp. 2254-2264
    • Perrotti, D.1    Jamieson, C.2    Goldman, J.3    Skorski, T.4
  • 51
    • 37049024761 scopus 로고    scopus 로고
    • C-myc repression of TSC2 contributes to control of translation initiation and Myc-induced transformation
    • Ravitz MJ, Chen L, Lynch M, Schmidt EV. 2007. c-myc repression of TSC2 contributes to control of translation initiation and Myc-induced transformation. Cancer Res 67: 11209-11217.
    • (2007) Cancer Res , vol.67 , pp. 11209-11217
    • Ravitz, M.J.1    Chen, L.2    Lynch, M.3    Schmidt, E.V.4
  • 53
    • 0034644525 scopus 로고    scopus 로고
    • TOR, a central controller of cell growth
    • Schmelzle T, Hall MN. 2000. TOR, a central controller of cell growth. Cell 103: 253-262.
    • (2000) Cell , vol.103 , pp. 253-262
    • Schmelzle, T.1    Hall, M.N.2
  • 54
  • 56
    • 13944252067 scopus 로고    scopus 로고
    • The life cycle of C-myc: From synthesis to degradation
    • Sears RC. 2004. The life cycle of C-myc: From synthesis to degradation. Cell Cycle 3: 1133-1137.
    • (2004) Cell Cycle , vol.3 , pp. 1133-1137
    • Sears, R.C.1
  • 58
    • 0037126303 scopus 로고    scopus 로고
    • Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage
    • Seoane J, Le HV, Massague J. 2002. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419: 729-734.
    • (2002) Nature , vol.419 , pp. 729-734
    • Seoane, J.1    Le, H.V.2    Massague, J.3
  • 59
    • 0030944985 scopus 로고    scopus 로고
    • Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
    • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593-602.
    • (1997) Cell , vol.88 , pp. 593-602
    • Serrano, M.1    Lin, A.W.2    McCurrach, M.E.3    Beach, D.4    Lowe, S.W.5
  • 60
    • 0017647580 scopus 로고
    • Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma
    • Staal SP, Hartley JW, Rowe WP. 1977. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci 74: 3065-3067.
    • (1977) Proc Natl Acad Sci , vol.74 , pp. 3065-3067
    • Staal, S.P.1    Hartley, J.W.2    Rowe, W.P.3
  • 61
    • 0025251664 scopus 로고
    • Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
    • Strasser A, Harris AW, Bath ML, Cory S. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331-333.
    • (1990) Nature , vol.348 , pp. 331-333
    • Strasser, A.1    Harris, A.W.2    Bath, M.L.3    Cory, S.4
  • 62
    • 74549193993 scopus 로고    scopus 로고
    • EGF receptor in relation to tumor development:Molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors
    • Takeuchi K, Ito F. 2010. EGF receptor in relation to tumor development:Molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS J 277: 316-326.
    • (2010) FEBS J , vol.277 , pp. 316-326
    • Takeuchi, K.1    Ito, F.2
  • 63
    • 0036285034 scopus 로고    scopus 로고
    • C-Myc can include DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability
    • Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. 2002. c-Myc can include DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031-1044.
    • (2002) Mol Cell , vol.9 , pp. 1031-1044
    • Vafa, O.1    Wade, M.2    Kern, S.3    Beeche, M.4    Pandita, T.K.5    Hampton, G.M.6    Wahl, G.M.7
  • 64
    • 33748192942 scopus 로고    scopus 로고
    • The Myc oncoprotein as a therapeutic target for human cancer
    • Vita M, Henriksson M. 2006. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16: 318-330.
    • (2006) Semin Cancer Biol , vol.16 , pp. 318-330
    • Vita, M.1    Henriksson, M.2
  • 65
    • 0036632368 scopus 로고    scopus 로고
    • The phosphatidylinositol 3- kinase AKT pathway in human cancer
    • Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3- kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
    • (2002) Nat Rev Cancer , vol.2 , pp. 489-501
    • Vivanco, I.1    Sawyers, C.L.2
  • 66
    • 0037025173 scopus 로고    scopus 로고
    • Cancer. Addiction to oncogenes-The Achilles heal of cancer
    • Weinstein IB. 2002. Cancer. Addiction to oncogenes-The Achilles heal of cancer. Science 297: 63-64.
    • (2002) Science , vol.297 , pp. 63-64
    • Weinstein, I.B.1
  • 68
    • 77956268839 scopus 로고    scopus 로고
    • Understanding resistance to EGFR inhibitors-impact on future treatment strategies
    • Wheeler DL, Dunn EF, Harari PM. 2010. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493-507.
    • (2010) Nat Rev Clin Oncol , vol.7 , pp. 493-507
    • Wheeler, D.L.1    Dunn, E.F.2    Harari, P.M.3
  • 70
    • 51849111556 scopus 로고    scopus 로고
    • PI3K pathway alterations in cancer: Variations on a theme
    • Yuan TL, Cantley LC. 2008. PI3K pathway alterations in cancer: Variations on a theme. Oncogene 27: 5497-5510.
    • (2008) Oncogene , vol.27 , pp. 5497-5510
    • Yuan, T.L.1    Cantley, L.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.